e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cystic fibrosis lung disease: what do we measure? What do we know?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis?
S. Al-Saleh, S. Dell, H. Grasemann, Y. Yau, V. Waters, S. Martin, F. Ratjen (Toronto, ON, Canada)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session:
Cystic fibrosis lung disease: what do we measure? What do we know?
Session type:
Electronic Poster Discussion
Number:
341
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Al-Saleh, S. Dell, H. Grasemann, Y. Yau, V. Waters, S. Martin, F. Ratjen (Toronto, ON, Canada). Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis?. Eur Respir J 2007; 30: Suppl. 51, 341
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2009; 33: 361-364
Year: 2009
Microbiology of induced sputum
vs
oropharyngeal culture in cystic fibrosis patients not producers of spontaneous sputum
Source: Eur Respir J 2007; 30: Suppl. 51, 647s
Year: 2007
Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis in subjects in airway colonization
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
Sputum biomarkers of inflammatory in children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
Sputum biomarkers of inflammatory in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Immunometabolic markers and the sputum microbiome in bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021
Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples
Source: Eur Respir J 2011; 38: 1486-1487
Year: 2011
Accompanying asthma in cystic fibrosis (CF) and non-CF bronchiectatic patients: could we detect it with AMP bronchoprovocation and sputum properties?
Source: Eur Respir J 2007; 30: Suppl. 51, 374s
Year: 2007
Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Induced sputum and respiratory function in pulmonary fybrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 178s
Year: 2003
Using sputum proteomics to develop a test for reflux aspiration in cystic fibrosis patients
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Bacterial pathogens in sputum and pharyngeal specimens in elderly chronic lung disease patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
The aid of gastric and bronchial lavage to diagnosis in patients with the suspicion of lung tuberculosis and negative sputum smear for AFB
Source: Eur Respir J 2001; 18: Suppl. 33, 496s
Year: 2001
Gastric washing for diagnosis of tuberculosis in patients unable to expectorate sputum: promising result
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Pulmonary function testing: an useful oracle for predicting the pattern of bacterial pathogens in sputum of patients with acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003
Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 399s
Year: 2003
Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept